| Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial HS Shehata, EH Esmail, A Abdelalim, S El-Jaafary, A Elmazny, A Sabbah, ... Journal of pain research, 771-777, 2016 | 54 | 2016 |
| Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study SM Hamdy, M Abdel-Naseer, NM Shalaby, AN Elmazny, AA Nemr, ... Neuropsychiatric Disease and Treatment, 1895-1903, 2017 | 42 | 2017 |
| Association between miRNA-146a and Polymorphisms of its Target Gene, IRAK1, Regarding Susceptibility to and Clinical Features of Systemic Lupus … DA Labib, OG Shaker, RM El Refai, SA Ghoniem, A Elmazny Laboratory medicine 50 (1), 34-41, 2019 | 28 | 2019 |
| Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case–control study R Magdy, A Elmazny, SH Soliman, EH Elsebaie, SH Ali, AM Abdel Fattah, ... The Journal of Headache and Pain 23 (1), 101, 2022 | 25 | 2022 |
| Long noncoding RNAs APOA1-AS, IFNG-AS1, RMRP and their related biomolecules in Egyptian patients with relapsing-remitting multiple sclerosis: relation to disease activity and … HR Ghaiad, AN Elmazny, MM Nooh, MM El-Sawalhi, AA Shaheen Journal of advanced research 21, 141-150, 2020 | 21 | 2020 |
| Interferon-beta-induced headache in patients with multiple sclerosis: frequency and characterization A Elmazny, SM Hamdy, M Abdel-Naseer, NM Shalaby, HS Shehata, ... Journal of Pain Research, 537-545, 2020 | 20 | 2020 |
| Clinical patterns and outcomes of status epilepticus in patients with tuberous sclerosis complex HS Shehata, HM AbdelGhaffar, M Nasreldin, A Elmazny, A Abdelalim, ... Therapeutics and clinical Risk management, 779-785, 2017 | 19 | 2017 |
| Managing disease-modifying therapies and breakthrough activity in multiple sclerosis patients during the COVID-19 pandemic: toward an optimized approach SM Hamdy, M Abdel-Naseer, HS Shehata, A Hassan, A Elmazny, ... Therapeutics and Clinical Risk Management, 651-662, 2020 | 18 | 2020 |
| Neurological manifestations in a cohort of Egyptian patients with COVID-19: a prospective, multicenter, observational study DA Mekkawy, S Hamdy, M Abdel-Naseer, HS Shehata, AA Halfawy, ... Brain Sciences 12 (1), 74, 2022 | 16 | 2022 |
| Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect M Farghaly, DW Langdon, NM Shalaby, HS Shehata, NT Abokrysha, ... The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57, 1-8, 2021 | 15 | 2021 |
| Development and validation of an Arabic-language headache questionnaire for population-based surveys NA El-Sherbiny, HS Shehata, H Amer, A Elmazny, M Masoud, H Helmy, ... Journal of Pain Research, 1289-1295, 2017 | 15 | 2017 |
| Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study AH Ragab, NA Kishk, A Hassan, O Yacoub, L El Ghoneimy, A Elmazny, ... Headache: The Journal of Head and Face Pain 61 (10), 1493-1498, 2021 | 12 | 2021 |
| Management strategies of patients with neuromyelitis optica spectrum disorder during the COVID-19 pandemic era SM Hamdy, M Abdel-Naseer, HS Shehata, NM Shalaby, A Hassan, ... Therapeutics and Clinical Risk Management, 759-767, 2020 | 11 | 2020 |
| Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination A Elmazny, R Magdy, M Hussein, EH Elsebaie, SH Ali, AM Abdel Fattah, ... European archives of psychiatry and clinical neuroscience 273 (6), 1349-1358, 2023 | 9 | 2023 |
| Vitamin D status of untreated children and adolescent Egyptian patients with genetic generalized epilepsy: A case–control study A Elmazny, H Amer, L Rashed, S Khalil, R Magdy Epilepsy & Behavior 103, 106840, 2020 | 8 | 2020 |
| Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients SM Hamdy, M Abdel-Naseer, NM Shalaby, A Elmazny, M Girgis, MA Nada, ... Neuropsychiatric Disease and Treatment, 631-640, 2018 | 8 | 2018 |
| Apoptotic protease activating factor-1 gene and MicroRNA-484: A possible interplay in relapsing remitting multiple sclerosis DAW Mohamed, HM Selim, A Elmazny, A Genena, MM Nabil Multiple Sclerosis and Related Disorders 58, 103502, 2022 | 6 | 2022 |
| Toll-like receptors 2 and 4 expression on peripheral blood lymphocytes and neutrophils of Egyptian multiple sclerosis patients DA Labib, I Ashmawy, A Elmazny, H Helmy, RS Ismail International Journal of Neuroscience 132 (4), 323-327, 2022 | 5 | 2022 |
| The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt NA Kishk, W Abdelfattah, NM Shalaby, HS Shehata, A Hassan, MI Hegazy, ... BMC neurology 21, 1-8, 2021 | 5 | 2021 |
| Reliability of BICAMS (Arabic version) in Egyptian multiple sclerosis patients N Kishk, N Shalaby, H Shehata, A Hassan, M Hegazy, A Elmazny, ... Multiple Sclerosis Journal 23, 155-156, 2017 | 5 | 2017 |
